Overview
This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.
Eligibility
Inclusion Criteria:
- subject signed informed consent
- Confirmed superficial or nodular basal cell or squamous cell carcinoma
- Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
- >5 mm of residual tumor
- tumors < 3 cm
- Capable of complying with Patient Release Instructions
Exclusion Criteria:
- Is unable or unwilling to comply with the protocol requirements
- Pregnant or breast feeding
- Metastases